About Daxor
Daxor is a company based in New York (United States) founded in 1970. Daxor offers products and services including BVA-100. Daxor operates in a competitive market with competitors including Hemcheck, Pathshodh Healthcare, Cellmic, Epocal and Essenlix, among others.
- Headquarter New York, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Daxor Corporation
-
Annual Revenue
-$135.67 K (USD)-100.39as on Dec 31, 2024
-
Net Profit
$536.33 K (USD)91.11as on Dec 31, 2024
-
EBITDA
$621.42 K (USD)88.46as on Dec 31, 2024
-
Latest Funding Round
$305 K (USD), Grant
Sep 11, 2023
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Daxor
Daxor is a publicly listed company on the NASDAQ with ticker symbol DXR in USA, operating in the Miscellaneous sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Daxor
Daxor offers a comprehensive portfolio of products and services, including BVA-100.
Device for accurate blood volume measurement in medical diagnostics.
People of Daxor
Unlock access to complete
Unlock access to complete
Funding Insights of Daxor
Investors in Daxor
Daxor has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Institute of General Medical Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Basic research is supported to advance medical sciences.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Daxor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Daxor
Investment portfolio details for Daxor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Daxor
Detailed financials for Daxor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Daxor Comparisons
Peer comparison for Daxor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Daxor
Daxor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemcheck, Pathshodh Healthcare, Cellmic, Epocal and Essenlix, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Devices for detecting hemolyzed blood samples are provided by Hemcheck.
|
|
| Locked | Locked | Locked |
Developer of handheld medical diagnostic devices. This company develops and manufactures portable devices for measuring multiple biomarkers related to diabetes, kidney disease, anemia, malnutrition, and liver ailments. The devices provide rapid, point-of-care diagnostic testing, enabling healthcare professionals to obtain results quickly. The technology aims to improve healthcare access and affordability.
|
|
| Locked | Locked | Locked |
Rapid test readers are developed for chromatographic and fluorescent assays.
|
|
| Locked | Locked | Locked |
Biochips and solid-state diagnostic devices for blood testing are developed.
|
|
| Locked | Locked | Locked |
Mobile health self-test platform is provided using nanotechnology and AI.
|
Detailed competitors of Daxor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Daxor
Complete news archive for Daxor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daxor
Daxor was founded in 1970 and raised its 1st funding round 50 years after it was founded.
Daxor is headquartered in New York, United States. It is registered at New York, New York, United States.
Daxor was founded in 1970 in New York, United States, and operates in the medical device sector. The BVA-100 blood volume analyzer is produced by the company, with measurements completed in under 60 minutes. This tool is utilized to assess blood volume and support treatment decisions for conditions including congestive heart failure, anemia, hypertension, and dialysis needs. Operations focus on healthcare diagnostics across the United States.
Daxor's top competitors include Pathshodh Healthcare, Cellmic and Hemcheck.
Daxor offers BVA-100.
Yes, Daxor is publicly traded on NASDAQ under the ticker symbol DXR.
Daxor has 2 investors. Key investors include HHS, and National Institute of General Medical Sciences.
The ticker symbol of Daxor is DXR on NASDAQ.